PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-117.41%
Negative net income growth while CNQ stands at 22.38%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-3.65%
Negative yoy D&A while CNQ is 0.57%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-300.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-34.78%
Negative yoy SBC while CNQ is 179.58%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-2135.29%
Both reduce yoy usage, with CNQ at -561.90%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-1001.95%
AR is negative yoy while CNQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
141.16%
AP growth of 141.16% while CNQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-2135.29%
Both reduce yoy usage, with CNQ at -561.90%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
33766.67%
Some yoy increase while CNQ is negative at -1396.00%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-7.43%
Both yoy CFO lines are negative, with CNQ at -39.45%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-7.13%
Negative yoy CapEx while CNQ is 12.13%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-1293.71%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Growth well above CNQ's 307.02%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-2.96%
We reduce yoy invests while CNQ stands at 22.54%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-6900.00%
Both yoy lines negative, with CNQ at -340.76%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
35.69%
We have some buyback growth while CNQ is negative at -29.24%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.